Assure Tech

Executive Summary

Assure Tech is a Hangzhou-based diagnostics company specializing in rapid test kits for infectious diseases, particularly lateral flow assays and point-of-care solutions. Founded in 2001, the company gained significant visibility during the COVID-19 pandemic through its antigen tests. With a workforce of 200-500 employees, Assure Tech operates as a private commercial-stage entity. The company is well-positioned to capitalize on the ongoing demand for rapid diagnostic solutions, especially in emerging markets where point-of-care testing is critical. Its expertise in lateral flow technology provides a foundation for expanding into other infectious disease areas, such as respiratory viruses, sexually transmitted infections, and tropical diseases. However, the post-pandemic slowdown in COVID-19 testing demand presents a near-term revenue challenge, necessitating diversification. Assure Tech's ability to secure regulatory approvals in new geographies and develop multiplex assays will be key to sustaining growth. The company's private status limits visibility, but its established manufacturing capabilities and distribution network in China offer a competitive edge.

Upcoming Catalysts (preview)

• Q4 2026WHO Prequalification for HIV/Syphilis Rapid Test60% success
• Q2 2026CE Marking for Multiplex Respiratory Panel70% success
• Q3 2026Partnership for Distribution in Southeast Asia50% success